Document:

<PAGE>   1
                                                                   EXHIBIT 10.27

                                SERVICE AGREEMENT

     THIS SERVICE AGREEMENT (the "Agreement") is entered into this 30th day of
September, 2000 (the "Effective Date"), by and between SYNERPHY OF ROME, INC., a
Tennessee corporation, formerly known as PhyCor of Rome, Inc. ("SynerPhy"), and
HARBIN CLINIC, L.L.C., a Georgia professional limited liability company
("Group"):

                                   WITNESSETH:

     WHEREAS, Group is a physician group located in the Rome, Georgia area;

     WHEREAS, SynerPhy is in the business of providing support services to
physician groups;

     WHEREAS, SynerPhy and Group are parties to that certain Service Agreement,
dated May 1, 1996 (the "Service Agreement"), and SynerPhy's sole shareholder,
PhyCor, Inc. ("PhyCor"), and Group are parties to that certain Asset Purchase
Agreement dated as of May 1, 1996, both of which are being terminated
simultaneously with the execution of this Agreement pursuant to that certain
Termination and Release Agreement of even date herewith;

     WHEREAS, simultaneously with the execution of this Agreement, Group and
SynerPhy are entering into an Asset Purchase Agreement of even date herewith for
the purchase of the assets and the assumption of liabilities of SynerPhy as set
forth therein (the "Asset Purchase Agreement"); and

     WHEREAS, SynerPhy desires to enter into this Agreement with Group pursuant
to which Group will purchase from SynerPhy and SynerPhy will deliver to Group
services relating to the business operations of Group.

     NOW, THEREFORE, in consideration of the mutual covenants and agreements
herein contained, Group hereby agrees to purchase the management and support
services herein described and SynerPhy agrees to provide such services on the
terms and conditions provided below.

                         I. RELATIONSHIP OF THE PARTIES

     1.1 Independent Relationship; Relationship with Group. Group, on the one
hand, and SynerPhy, on the other hand, intend to act and perform as independent
contractors, and the provisions hereof are not intended to create any
partnership, joint venture, agency or

                                       1
<PAGE>   2

employment relationship between such parties. Notwithstanding the services to be
performed by SynerPhy hereunder, SynerPhy and Group agree that Group shall
retain the authority to direct the medical, professional, and ethical aspects of
the medical practice of Group. SynerPhy shall neither exercise control over nor
interfere with the physician-patient relationship, which shall be maintained
strictly between the physicians of Group and their patients.

     1.2 Patient Referrals. The parties agree that the benefits to Group
hereunder do not require, are not payment for, and are not in any way contingent
upon the admission, referral or any other arrangement for the provision of any
item or service offered by SynerPhy to any patients in any facility or
laboratory managed or operated by SynerPhy.

     1.3. Recommendations by SynerPhy. Group acknowledges that SynerPhy's
ability to successfully perform the services described hereunder, including the
ability to timely perform such services, will depend upon the full cooperation
of Group and its employees, and Group agrees to give full consideration to all
recommendations made by SynerPhy related to the operations of Group, provided
that the final decision as to whether to act upon any such recommendations shall
be made by Group, in its sole discretion. Group further acknowledges and agrees
that SynerPhy shall not be held accountable or responsible to Group or any third
party in the event that Group's failure to act on such SynerPhy recommendations
results, directly or indirectly, in negative financial and/or operational
consequences to Group and further agrees that the occurrence of such
consequences shall not be deemed, or cited as evidence by Group of a breach of
this Agreement by SynerPhy.

                             II. DUTIES OF SYNERPHY

     2.1 Performance of Services. Group hereby engages SynerPhy to provide the
services set forth in this Article II for the benefit of Group. The services
provided by SynerPhy shall be performed in a manner consistent with other
professionals providing consulting and financial services to medical practices.
Group hereby acknowledges that SynerPhy needs and shall be granted reasonable
access to the data and systems of Group relating to the operations of Group so
that SynerPhy may perform its duties pursuant to this Agreement. SynerPhy and
Group agree that Group and only Group (or any permitted assignee hereunder) will
perform the medical functions of its practice. SynerPhy will have no authority,
directly or indirectly, to perform, and will not perform, any medical function.

     2.2 Duties and Responsibilities of SynerPhy. Except as may be provided
herein, the parties acknowledge and agree that SynerPhy is being engaged by
Group to provide only those specific services and to perform only those specific
duties and responsibilities set forth in this Agreement, and that SynerPhy is
not assuming responsibility for the general management of Group's operations.
SynerPhy shall have the following duties and responsibilities pursuant to this
Agreement.

                                       2
<PAGE>   3

         (a) SynerPhy shall assist with the preparation of the annual capital
and operating budgets of Group reflecting Group's anticipated revenues and
expenses and sources and uses of capital. The proposed operating and capital
budgets on which SynerPhy assists shall be subject to the modification and
approval by Group. In addition, representatives of SynerPhy or PhyCor shall meet
at least annually with representatives of Group at a time and place specified by
Group as part of the foregoing budget process to discuss SynerPhy's services
anticipated to be needed and provided to Group by SynerPhy during the next year.

         (b) On or before March 30 of each year, SynerPhy shall provide a
proposed strategic plan for Group. Such plan shall set forth the efforts,
methods and resources SynerPhy believes are needed to implement the proposed
strategic plan and to which they are willing to commit their services. The
strategic plan shall include an analysis of the staffing needs of Group and
shall recommend for review and approval by Group efficient practice work flows
and a determination of the combination of physicians and support staff which is
needed based on the applicable patient population. SynerPhy shall also assist
Group in the development of a fixed asset, drug and supply inventory system for
Group.

         (c) SynerPhy shall annually provide a written evaluation of the
physician income distribution plan utilized by Group and submit for review to
Group any recommended additional alterations thereto. Such evaluation and review
shall include proposed alterations to the form of employment agreements entered
into between Group and its physician employees, it being understood that Group
solely shall determine the content of such employment agreements.

         (d) SynerPhy shall regularly, but no less than annually, advise Group
as to the relationship between the performance of medical functions and the
overall administrative and business functioning of Group and shall develop and
periodically revise a physicians' communication plan for Group. Personnel of
Group who provide medical care services shall in no event be subject to any
direction or control by, or obligation to, SynerPhy.

         (e) SynerPhy shall regularly, but no less than annually, assist the
Group's administrative staff with a review of the operations of the Group's
billing and collections department and its methods and procedures and provide
recommend for changes, if any. With the prior written approval of Group,
SynerPhy may engage third parties at its own expense that shall assist SynerPhy
in making recommendations to Group with respect to the foregoing. SynerPhy shall
not be obligated for any costs or expenses associated with the billing and
collection of Group accounts and any legal proceedings instituted by Group with
respect to collections thereof. The parties acknowledge and agree that coding
for procedures performed by Group's providers shall be the sole responsibility
of Group and that neither SynerPhy nor PhyCor shall have any control

                                       3
<PAGE>   4

over such coding or other day-to-day functions of the billing and collections
department. In connection with the foregoing services, SynerPhy shall arrange
for periodic audits of the coding practices and procedures used in the billing
department.

         (f) On or before March 30 of each year, SynerPhy shall review and
assess the information systems utilized by Group and shall make recommendations
to Group as to alterations to the existing information system or the necessity
of obtaining new or additional systems to meet the needs of Group. If Group
determines to proceed with alterations to the information systems as recommended
by SynerPhy, Group shall select the vendor and systems to be acquired by Group,
as applicable, or to be used in any upgrade, replacement or alteration to such
systems. Any costs and expenses associated with the implementation of any
recommendations approved by Group and the purchase of any equipment, fixtures,
inventory, supplies, software or services in connection therewith shall be at
the sole expense of Group. Pursuant to the Asset Purchase Agreement, Group is
purchasing from SynerPhy all of the computer hardware and equipment owned by
SynerPhy and the owned and licensed software currently contained on or
pertaining to such computer hardware, other than software proprietary to
SynerPhy or PhyCor. During the term of this Agreement, SynerPhy and PhyCor shall
make its proprietary software available to Group for its use at no additional
cost to Group. After termination of this Agreement, at Group's request, SynerPhy
shall license such software to Group for a mutually agreed upon sublicensing
fee.

         (g) SynerPhy shall assist Group in regularly assessing and monitoring
the central business office operations of Group and shall recommend to Group
alterations to such operations. Such review shall include a review of central
business office procedures, staffing levels and the operations of the central
business office. SynerPhy shall also review and assess a management action plan
and operations checklist devised by Group relating to the central business
office. SynerPhy shall also advise and assist Group in assessing Group's Human
Resources Department and Medical Records Department. Any costs and expenses
associated with the implementation of any recommendations approved by Group
shall be at the sole cost of Group.

         (h) SynerPhy shall assist Group in recruiting additional physicians
solely by reviewing and making recommendations as to the administrative
functions related to the recruitment of physicians. Group shall make the
ultimate decision as to the suitability of any physician to become associated
with Group. All recruited physicians employed by Group shall be solely employees
of Group and not of SynerPhy to the extent such physicians are hired as
employees. Group shall be solely responsible for any expenses incurred in the
recruitment of physicians, including, but not limited to, employment agency
fees, and relocation and interviewing expenses.

         (i) SynerPhy shall conduct, no less than annually, a comprehensive
review of all managed care contracts of Group, and shall consult with Group and
make

                                       4
<PAGE>   5

recommendations to Group on professional or clinical matters relating thereto.

         (j) SynerPhy shall, at the request of Group, review and analyze third
party contracts, including vendor contracts and real estate leases, to which
Group is a party or into which Group is contemplating entering. SynerPhy shall
also evaluate the facility utilization and make recommendations as to facility
utilization, consolidations, space planning and office relocations. Following
its initial review of the foregoing, SynerPhy shall, during the term hereof,
provide oversight and on-going review of such third party contracts. The parties
acknowledge and agree that neither SynerPhy nor PhyCor, nor any representative
or employee of them, shall have any power, authority or obligation to execute or
otherwise enter into any contract on behalf of Group or in connection with
services provided to Group. All contracts related to the operations of Group
will be executed and entered into only by an authorized employee or officer of
Group.

         (k) In addition to the duties and responsibilities of SynerPhy outlined
above and elsewhere in this Agreement, SynerPhy shall make available for the
benefit of Group such other services which are offered from time to time by
PhyCor for the benefit of PhyCor's affiliated physician groups to the extent
requested by Group. Group acknowledges and agrees that such other services will
change during the term of this Agreement, with some programs being deleted and
new programs added, and that the commitment provided herein as to access to such
other services shall be only to the extent of the services provided from time to
time by PhyCor. If new services are offered by PhyCor or its affiliates in
addition to the services provided pursuant to this Agreement, but not as a
substitute for such services, Group may purchase such additional services for a
mutually agreed upon price. SynerPhy agrees that it will maintain adequate
personnel and resources to provide such additional services to Group as set
forth herein, and that it shall make such personnel and resources available to
Group upon reasonable notice and at reasonable times during the term of this
Agreement. SynerPhy acknowledges that even though services offered by SynerPhy
and PhyCor may change from time to time during the term hereof, SynerPhy and
PhyCor will retain as a corporate purpose the provision of services for the
benefit of physicians and their patients.

         (l) SynerPhy acknowledges that Group has adopted a regulatory
compliance plan, and SynerPhy agrees that it shall assist Group in the
implementation of such plan, to the extent requested by Group. Group and
SynerPhy shall periodically, but no less than annually, review the regulatory
compliance plan and discuss revisions, additions and deletions to such
compliance plan. SynerPhy shall assist Group in implementing such revisions,
additions, and deletions, but the parties agree that the final determination as
to whether Group will adopt and implement any changes to its compliance plan
will be made by Group in its sole discretion.

         (m) Group understands and agrees that in performing the services
described in Sections 2.2(a) through (l), SynerPhy may, with Group's prior
written approval, engage third parties to provide expertise or personnel to
assist SynerPhy under this Agreement. SynerPhy, in

                                       5
<PAGE>   6

its sole discretion, shall be responsible for selecting any such third parties
once Group has approved the engagement thereof. Any engagement by SynerPhy of
such third parties approved by Group shall be entered into in the name of Group
and all costs and expenses associated with such third party engagement shall be
at Group's sole expense. The prior written approval of Group of any third party
engagement shall include approval of the terms, including the financial terms,
of such engagement. Provided, however, that this provision for the engagement of
third parties and all other provisions contained in this Agreement which permit
SynerPhy, with Group's prior approval, to engage third parties to provide
services to Group, are not intended, nor shall this or any other provision of
this Agreement be interpreted to decrease SynerPhy's duties and obligations
hereunder, and shall not be a substitute for the services to be provided by
SynerPhy under this Agreement.

         (n) Notwithstanding the terms of Section 3.10 below, SynerPhy shall
make available to Group lease financing for the acquisition of equipment to be
used in the operation of Group up to $750,000 annually. The lease terms would be
for five (5) years each at a floating rate equal to the prime rate. There would
be a nominal purchase option at the end of each of the leases. Group solely
shall determine whether or not to lease equipment and whether or not to use
SynerPhy as the source of the leased equipment. No new lease agreements with
SynerPhy would be entered into after the fifth anniversary of this Agreement.

     2.3 SynerPhy Personnel. (a) SynerPhy shall provide to Group the services of
designated employees of PhyCor. All costs associated with these individuals,
including, but not limited to, compensation, benefits and severance expenses,
payroll taxes, and travel and out-of-pocket expenses, will be the sole
obligation of SynerPhy. Group shall make available to SynerPhy the services of
Group's administrative staff to assist SynerPhy in the performance of its
services under this Agreement, including, without limitation, the Executive
Director and Chief Financial Officer of Group.

         (b) Group agrees that it will not, either directly or indirectly,
solicit for employment any individuals employed by SynerPhy or PhyCor during the
term of this Agreement or for a period of twelve (12) months following the
termination of this Agreement; provided, however, that the foregoing shall not
prohibit Group from employing any such individual after he or she is no longer
employed by SynerPhy or PhyCor so long as such individual approaches Group
seeking such employment after they are no longer employed by SynerPhy or PhyCor.

     2.4 Certain Contracting. In the event that, during the term hereof, Group
elects to pursue the formation of an IPA or similar physician organization,
prior to selecting a manager of the organization, Group will notify SynerPhy of
its intent and will allow SynerPhy thirty (30) days within which to develop and
present to Group a proposal whereby PhyCor's affiliate, North American Medical
Management, Inc, or one of its subsidiaries, would manage the organization.
Notwithstanding the foregoing, the decision regarding who will be the manager of
the IPA or

                                       6
<PAGE>   7

physician organization will be made by Group, in its sole discretion.

     2.5 Events Excusing Performance. SynerPhy shall not be liable to Group for
failure to perform any of the services required herein in the event of strikes,
lock-outs, calamities, acts of God, unavailability of supplies, the failure of
hardware or software to function in the manner intended, whether such problems
arises in hardware or software owned by Group, any vendor or customer of Group
or any other third party (including but not limited to government agencies), or
other events over which SynerPhy has no control for so long as such events
continue, and for a reasonable period of time thereafter.

     2.6. SynerPhy Overhead Costs. The parties hereto agree that overhead costs
of SynerPhy, including travel, meals and lodging expenses of employees of
SynerPhy performing services on behalf of Group under this Agreement, shall be
the sole obligation and responsibility of SynerPhy.

                            III. OBLIGATIONS OF GROUP

     3.1 Professional Services. Group shall provide professional services to
patients in compliance at all times with ethical standards, laws and regulations
applying to the medical profession. Group shall ensure that each physician
associated with Group to provide medical care to patients of Group is licensed
by the State of Georgia. Group shall carry out a program to monitor the quality
of medical care practiced at Group.

     3.2 Medical Practice. Group shall comply with all applicable federal, state
and local laws, rules and ordinances and all applicable standards of medical
care.

     3.3 Employment of Physicians. Group shall have complete control of and
responsibility for the hiring, compensation, supervision, evaluation and
termination of the physician employees of Group, although SynerPhy may consult
with Group respecting such matters. Group shall be responsible for the payment
of such physician employee's salaries and wages, benefits, payroll taxes and all
other taxes and charges now or hereafter applicable to them. Group shall also be
responsible solely for the cost of physicians' membership in professional
associations, and their continuing professional education. With respect to
physicians, Group shall only employ and contract with licensed physicians
meeting applicable credentialing guidelines established by Group. Group shall
consider guidelines suggested by SynerPhy from time to time in establishing the
duties and responsibilities of the officers of Group and shall also consider
guidelines suggested by SynerPhy for the development and implementation of a
succession plan that contemplates the efficient transition of leadership for
Group upon the death, disability, resignation, removal or other termination of
the key leadership positions of Group.

                                       7
<PAGE>   8

     3.4 Employment of Personnel. Group shall employ all personnel necessary to
conduct the day-to-day operations of Group, including the Executive Director,
Chief Financial Officer and Chief Operating Officer, if applicable. No employee
of Group providing medical services shall be subject to the supervision of any
SynerPhy or PhyCor employee. Group shall be responsible solely for the payment
of such employee's salaries and wages, benefits, payroll taxes and all other
taxes and charges now or hereafter applicable to them, although at the request
of Group, SynerPhy shall consult with Group respecting such matters. The chief
administrative staff of Group shall be reasonably available to work with
SynerPhy and PhyCor personnel to implement the directives, plans, strategies and
services approved by Group.

     3.5 Access to Information and Data. Group understands and agrees that
SynerPhy must have access to financial and other operating data and systems
maintained by Group relating to the operations of Group to be able to provide
the services contemplated in this Agreement, including, but not limited to, the
performance initiatives described in Section 3.8. SynerPhy shall, with Group's
prior approval, be afforded reasonable access to all such information and data
of Group concerning the operations of Group, including, but not limited to,
financial data, physician data, patient level data to track clinical and
financial outcomes, accounts receivable data, accounts payable data, employee
payroll information, all systems and programs on which such data and information
are stored, all paper records and files where such information is held, and all
electronic records relating to the foregoing. Subject, in all instances, to
applicable federal and state laws and regulations, SynerPhy shall have the right
to aggregate and assimilate such data and information with and into similar data
and information from physician groups managed by PhyCor and its affiliates as
provided in Section 7.1 hereto. SynerPhy shall also be permitted reasonable
access to employees of Group who are responsible for maintaining and processing
all such information and data. Group also agrees to produce such reports based
on the foregoing data and information, as SynerPhy shall reasonably request from
time to time in connection with SynerPhy's performance of its duties under this
Agreement.

     3.6 Insurance. (a) Group shall provide to SynerPhy, upon SynerPhy's
request, evidence of Group's comprehensive professional liability insurance with
coverage levels of at least one million dollars per occurrence and three million
dollars in the aggregate, as well as general liability and umbrella insurance.
In no event shall SynerPhy be liable in any respect for any amounts not covered
by the foregoing policies, whether such non-coverage relates to satisfaction of
deductibles, claims in excess of policy limits, or otherwise.

         (b) Provided that SynerPhy's corporate registered agent is located in
Floyd County, Georgia, SynerPhy and PhyCor shall be named as an additional
insured under the comprehensive professional liability policies provided for in
Section 3.6(a) above. SynerPhy shall be provided the endorsement evidencing
SynerPhy and PhyCor being named as an additional insured no later than the
Effective Date and upon the annual renewal of such policies each policy year.
Group shall also provide that SynerPhy receive written notice from the carrier
of any

                                       8
<PAGE>   9

substantive changes to the policies and any cancellation or expiration of such
policies no less than thirty (30) days prior to the effective date of any such
change, cancellation or expiration. If for any reason SynerPhy's registered
corporate agent is not located in Floyd County, Georgia, SynerPhy and PhyCor
shall remain additional insureds for a period ending ninety (90) days following
written notice from Group that the requirements of this Section 3.6(b) have no
longer been met; provided, however, if SynerPhy's and PhyCor's registered agent
is again located in Floyd County, Georgia prior to the expiration of the
foregoing 90-day period, then SynerPhy and PhyCor shall remain additional
insureds as provided for above.

     3.7 Facilities. During the term of this Agreement, Group agrees to provide
or make available the offices and facilities occupied by Group as of the date
hereof to the extent reasonably necessary and during normal business hours for
SynerPhy to provide the services contemplated by this Agreement.

     3.8 Events Excusing Performance. Group shall not be liable to SynerPhy for
failure to perform any of the services required herein in the event of strikes,
lock-outs, calamities, acts of God, unavailability of supplies, the failure of
hardware or software to function in the manner intended, whether such problem
arises in hardware or software owned by Group, any vendor or customer of Group
or any other third party (including but not limited to government agencies), or
other events over which Group has no control for so long as such events
continue, and for a reasonable period of time thereafter.

     3.9 Attendance at Group Meetings. Group agrees that SynerPhy shall have the
right to have at least one person selected by SynerPhy in attendance at a
portion of each regularly scheduled meeting of the Board of Managers of Group so
that the SynerPhy representative may present information and answer questions
concerning the operations of Group and the provision of services by SynerPhy
pursuant to this Agreement. The SynerPhy representative shall not have the right
to remain in attendance for the remaining portions of Board meetings. Such
SynerPhy representative shall be provided with notice of each meeting of the
Board of Managers at which a SynerPhy representative is to make a presentation
in the same manner and at the same time as members of the Board of Managers.
Group acknowledges and agrees that Group's Board or other designated entities
represent the only formal forum at which SynerPhy can present proposals and
recommendations for the improvement of Group's practice. Group therefore agrees
to hold Board meetings on a regularly scheduled basis, and, if SynerPhy so
requests from time to time, Group agrees to call a special Board meeting as may
be reasonably requested by SynerPhy to hear specific proposals and/or
recommendations which SynerPhy deems important or time sensitive. Conversely,
upon reasonable notice from Group, SynerPhy agrees that a representative of
SynerPhy will attend meetings of the Board and Board committees of Group as
reasonably requested by Group.

     3.10 Responsibility to Provide Capital. Except as contemplated in Section

                                       9
<PAGE>   10

2.2(n) above, during the term hereof, Group shall have the sole responsibility
of providing capital and funding necessary to maintain Group's operations,
including, but not limited to, the responsibility to (i) enter into any
contracts, leases or agreements necessary or appropriate for the operations of
Group, (ii) pay for the recruitment, hiring and employment of any Group
personnel, or the costs of contracting with the third parties, necessary for the
provision of services on behalf of Group or at Group facilities, except as
otherwise provided herein, (iii) pay any operating and other expenses related to
the operations of Group, (iv) fund the purchase of any medical or other
equipment, furniture, fixtures, supplies and other assets necessary for the
operations of Group, (v) fund the cost of any renovations, repairs or upgrades
to Group's facilities or of moving from one facility to another, and (vi) incur
any other liabilities or fund any other capital requirements necessary or
appropriate for the operations of Group.

                           IV. FINANCIAL ARRANGEMENTS

     4.1 Fee.

         (a) Unless and until this Agreement is terminated as provided herein,
as consideration for the services being provided hereunder by SynerPhy, Group
shall pay SynerPhy a flat fee (the "Fee") equal to $1,400,000 per year, payable
in equal monthly amounts, for the first two (2) years under this Agreement. The
Fee shall increase to $1,500,000 per year, payable in equal monthly amounts,
beginning immediately following the end of the first two years under this
Agreement and shall remain at $1,500,000 for the remaining term of this
Agreement.

         (b) The Fee to be paid to SynerPhy under this Section 4.1 shall be
payable by the tenth (10th) day of the month following the month for which such
Fee is being paid.

     4.2 Reimbursement of Expenses. Each month during the term hereof, Group
will, in addition to the Fee, pay SynerPhy an amount sufficient to reimburse
SynerPhy for any costs incurred by SynerPhy that: (1) have the prior written
approval of Group; (2) are solely attributable to the Group's operations; (3)
are reasonably documented; and (4) which represent reasonable expenses incurred
by SynerPhy related to third parties who are employed consistent with terms of
this Agreement, and provide services to Group beyond those services for which
SynerPhy is obligated to provide to Group hereunder. Such amounts will be
delivered to SynerPhy within ten (10) days of Group's receipt of an invoice from
SynerPhy setting forth in detail the amount and nature of such expenses. It is
understood by the parties hereto that overhead expenses of PhyCor and SynerPhy
are the sole responsibility of PhyCor and SynerPhy and are not included for
purposes of this Section 4.2.

     4.3 Compensation Reasonable. Group and SynerPhy agree that the

                                       10
<PAGE>   11

compensation payable to SynerPhy under Sections 4.1 and 4.2 is being paid to
SynerPhy in consideration of the services performed by SynerPhy hereunder. The
parties further agree that such fees are fair and reasonable and have been
bargained for at arms' length.

                             V. TERM AND TERMINATION

     5.1 Term of Agreement. This Agreement shall commence on the Effective Date
and shall expire on the seventh (7th) anniversary hereof, unless earlier
terminated pursuant hereto.

     5.2 Termination by Group. Group may terminate this Agreement as follows:

         (a) In the event of the filing of a petition for voluntary bankruptcy
by SynerPhy or PhyCor or an assignment for the benefit of creditors by SynerPhy
or PhyCor, or upon other action taken or suffered, voluntarily or involuntarily,
under any federal or state law for the benefit of debtors by SynerPhy or PhyCor,
except for the filing of a petition in involuntary bankruptcy against SynerPhy
which is dismissed within thirty (30) days thereafter, Group may give notice of
the immediate termination of this Agreement.

         (b) In the event SynerPhy shall default in the performance of any duty
or obligation imposed upon it by this Agreement and such default shall continue
for a period of fifteen (15) days after written notice thereof has been given to
SynerPhy by Group, Group may terminate this Agreement.

         (c) In the event that any person or persons (as such term is used in
Sections 13(d) and 14(d) of the Securities Exchange Act of 1934) acquires or
acquires the right to vote, through acquisition, tender offer, proxy
solicitation, merger or consolidation, fifty percent (50%) or more of PhyCor's
then issued and outstanding Common Stock, or securities representing fifty
percent (50%) or more of the combined voting power of PhyCor's then issued and
outstanding securities; or PhyCor consolidates with, merges with or into or
transfers substantially all of its assets (as an entirety or substantially an
entirety in one transaction or a series of related transactions) to any person
(as defined above), Group may terminate this Agreement no earlier that ninety
(90) days following the consummation of such transactions; provided, however,
Group shall have no right to terminate this Agreement pursuant to this Section
5.2(c) if PhyCor is the surviving entity following such transactions, is the
entity formed by a consolidation or the entity into which PhyCor is merged, and
the surviving entity expressly assumes all the obligations of PhyCor under
PhyCor's guaranty of SynerPhy's performance under this Agreement and there is no
uncured event of default under this Agreement at the time of the consummation of
the foregoing transactions.

     5.3 Termination by SynerPhy. SynerPhy may terminate this Agreement as
follows:

                                       11
<PAGE>   12

         (a) In the event of the filing of a petition for voluntary bankruptcy
or an assignment for the benefit of creditors by Group, or upon other action
taken or suffered, voluntarily or involuntarily, under any federal or state law
for the benefit of debtors by Group, except for the filing of a petition in
involuntary bankruptcy against Group which is dismissed within thirty (30) days
thereafter, SynerPhy may give notice of the immediate termination of this
Agreement.

         (b) In the event Group shall materially default in the performance of
any duty or obligation imposed upon it by this Agreement, and such default shall
continue for a period of fifteen (15) days (or ten (10) days if the default by
Group is a failure to pay any amounts payable by Group to SynerPhy hereunder)
after written notice thereof has been given to Group by SynerPhy, SynerPhy may
terminate this Agreement.

     5.4 Actions after Termination or Expiration. In the event of a termination
of this Agreement for any reason whatsoever, the parties agree to the following:
within thirty (30) days after such termination, each party shall repay to the
other party any indebtedness owed to the other party existing at the time of
such termination, including, but not limited to, any unpaid Fee for services
previously rendered prior to the termination date or any expenses incurred by
SynerPhy which would otherwise have been reimbursed as provided in Article IV.
Each of the equipment leases, if any, referred to in Section 2.2(n) above shall
continue in effect as provided for in such leases, unless this Agreement expires
or is terminated by SynerPhy pursuant to Section 5.3(b) above, in which event
all amounts payable under such leases shall accelerate and be due and payable
upon the effective date of the termination or expiration of this Agreement.

                            VI. RESTRICTIVE COVENANTS

     6.1 The parties recognize that the services to be provided by SynerPhy
shall be feasible only if Group operates an active medical practice to which the
physicians associates with Group devote their full time and attention. To that
end, during the term of this Agreement, Group hereby covenants and agrees to
obtain and enforce written agreements from its physician members or shareholders
and physician employees in substantially the form of Exhibit 6.1 attached
hereto. Group acknowledges that it is in the best interests of Group and
SynerPhy to obtain and enforce such agreements (including specifically the
restrictive covenant and liquidated damage provisions contained therein as they
exist as of the date hereof) to maintain a stable, productive physician group.

                                       12
<PAGE>   13

             VII. RECORDS; OWNERSHIP OF INFORMATION; CONFIDENTIALITY

     7.1 Patient Records. During the term of this Agreement and upon and after
the termination of this Agreement, Group shall retain all patient medical
records maintained by Group or SynerPhy in the name of Group. Group shall, at
its option, be entitled to retain copies of financial and accounting records
relating to all services performed by SynerPhy. Notwithstanding the foregoing,
but subject in all instances to applicable federal and state laws and
regulations, SynerPhy may from time to time, with Group's prior written
approval, collect patient data and other information from Group which will be
aggregated and assimilated with similar information from physician groups
managed by PhyCor and its affiliates. Such aggregated data and all reports
containing such information shall be the exclusive property of PhyCor and its
affiliates and any commercialization of such data or information shall be for
the sole and exclusive benefit of PhyCor and its affiliates. Nothing contained
herein shall authorize SynerPhy or such entities affiliated with PhyCor to own
or use any patient information in violation of federal or state laws or
regulations or the patient's legal rights. SynerPhy shall ensure that
information regarding the name or identity of patients of Group is not included
in such aggregation of patient data or otherwise used in a way that is violative
of such patients' right of confidentiality or applicable federal or state laws
or regulations. Group shall have access at no expense to all such data and
reports obtained or prepared by SynerPhy and PhyCor in accordance with this
Paragraph including, reports on performance initiatives set forth in Section
3.8, and including, without limitation, all reports and other documents
containing all or part of such data or based upon such data.

     7.2 Records Owned by SynerPhy.Except as required herein, SynerPhy retains
all ownership and other rights in all systems, manuals, computer software,
materials, and other information, in whatever form, provided by or developed by
SynerPhy or entities affiliated with SynerPhy in the performance of its
obligations under this Agreement (the "SynerPhy Materials"). Nothing contained
herein shall be construed as a license or transfer of any such SynerPhy
Materials or any portion thereof to Group. Upon the expiration or termination
for any reason of this Agreement, SynerPhy shall have the right to retain all
such SynerPhy Materials, and Group shall, upon request of SynerPhy, deliver to
SynerPhy all such SynerPhy Materials. Group shall be allowed to retain only
those materials developed by Group and SynerPhy during the terms of this
Agreement and which Group uses in its operations.

     7.3 Access to Records. (a) During the term of this Agreement and subject to
all federal or state laws and regulations, Group shall provide to SynerPhy
complete access to the records and facilities of Group during normal business
hours in connection with the provision of services hereunder by SynerPhy.
SynerPhy shall also provide to Group complete access to the records and
facilities of SynerPhy which pertain to the services provided by SynerPhy on
behalf of Group pursuant to this Agreement.

         (b) Upon the written request of the Secretary of Health and Human

                                       13
<PAGE>   14

Services, the Comptroller General, or any of their authorized representatives,
SynerPhy shall make available those contracts, books, documents and records
necessary to certify the nature and extent of the costs of providing services
under this Agreement. Such inspection shall be available for up to four (4)
years after the rendering of such services. If SynerPhy carries out any of the
duties under this Agreement through a subcontract with a value of $10,000 or
more over a 12-month period with a related individual or organization, SynerPhy
agrees to include this requirement in any subcontract. This Section 7.3(b) is
included pursuant to and is governed by the requirements of Public Law 96-499,
Sec. 952 and the regulations promulgated thereunder.

                                       14
<PAGE>   15

     7.4 Confidentiality. Except as set forth herein and except for disclosure
to its bankers, underwriters, consultants or lenders, or as necessary or
desirable for conduct of business, no party hereto shall disseminate or release
to any third party any information regarding any provision of this Agreement, or
any financial or other information regarding the other party (past, present or
future) that was obtained by the party in the course of the negotiation of this
Agreement or in the course of the performance of this Agreement, without the
other party's prior written approval; provided, however, the foregoing shall not
apply to information which (i) is generally available to the public other than
as a result of a breach of the confidentiality provisions hereof; (ii) becomes
available on a non-confidential basis from a source other than the party or its
affiliates or agents, which source was not itself bound by a confidentiality
agreement, or (iii) which is required to be disclosed by law, including
securities laws or pursuant to court order. In addition, subject to applicable
federal and state laws or regulations and the prior written approval of Group,
SynerPhy may use general data and information obtained by SynerPhy in performing
its services under this Agreement in presenting examples of SynerPhy's services
to other potential purchasers of services, including data evidencing economic
improvements made for the benefit of Group as a result of SynerPhy's services
provided in this Agreement. Group also acknowledges that SynerPhy may use the
information obtained pursuant to this Agreement to implement similar
arrangements with other clinics and medical groups, except as otherwise
prohibited by federal or state laws or regulations, and that the use of the
information and data obtained during the terms of this Agreement in such context
shall in no event be a breach of the terms hereof.

                       VIII. INDEMNIFICATION; ARBITRATION

     8.1 Indemnification by Group. Group shall indemnify, hold harmless and
defend SynerPhy, its officers, directors, shareholders and employees, from and
against any and all liability, loss, damage, claim, causes of action, and
expenses (including reasonable attorneys' fees), whether or not covered by
insurance, caused or asserted to have been caused, directly or indirectly, by or
as a result of the performance of medical services or the performance of any
intentional acts, negligent acts or omissions by Group and/or its agents, and
employees during the term of this Agreement.

     8.2 Indemnification by SynerPhy. SynerPhy shall indemnify, hold harmless
and defend Group, its officers, shareholders, managers and employees, from and
against any and all liability, loss, damage, claim, causes of action, and
expenses (including reasonable attorneys' fees), whether or not covered by
insurance, caused or asserted to have been caused, directly or indirectly, by or
as a result of the performance of any intentional acts, negligent acts or
omissions by SynerPhy and/or its shareholders, agents, and employees during the
term of this Agreement.

     8.3 Rules Regarding Indemnification; Cumulative Remedies. The obligations
and liabilities of each indemnifying party hereunder with respect to claims
resulting from the

                                       15
<PAGE>   16

assertion of liability by the other party or third parties shall be subject to
the following terms and conditions:

         (a) The indemnified party shall give prompt written notice to the
indemnifying party of any claim which might give rise to a claim by the
indemnified party against the indemnifying party based on the indemnity
agreement contained in Sections 8.1 and 8.2 hereof, stating the nature and basis
of said claims and the amounts thereof, to the extent known.

         (b) The indemnified party shall not make any settlement of any claims
without the written consent of the indemnifying party, which consent shall not
be unreasonably withheld or delayed. The indemnifying party shall select counsel
in the applicable matter and shall provide, at its expense, a defense to the
litigation.

         (c) Except as herein expressly provided, the remedies provided in this
Article VIII shall be cumulative and shall not preclude assertions by any party
of any other rights or the seeking of any other rights or remedies against any
other party hereto.

     8.4 Binding Arbitration.

         (a) Any dispute or action arising out of or relating to this agreement
which the parties are unable to resolve, including any and all federal and state
statutory claims, federal and state public and private law issues and issues as
to what matters are subject to arbitration (hereinafter, an "applicable
action"), shall be determined solely and exclusively by arbitration in
accordance with the commercial arbitration rules of the American Arbitration
Association or any successor thereof ("AAA"). Prior to submitting any applicable
action to arbitration pursuant hereto, the parties agree to make themselves
available to meet and use their best efforts to resolve the applicable action in
following good faith negotiations.

         (b) In the event any party determines to submit an applicable action to
arbitration following compliance with the last sentence of 8.4 (a) above, such
party shall give written notice thereof to the other party. If the parties are
otherwise unable to agree on a mutually acceptable arbitrator within ten (10)
days following the date of such written notice, the arbitrator shall be an
arbitrator then affiliated with the American Arbitration Association ("AAA") in
Atlanta, Georgia (a "qualified arbitrator"). The rules of arbitration then in
effect for AAA shall be applied in such arbitration. No qualified arbitrator
shall have any financial interest in either of the parties to the arbitration or
the outcome of the arbitration.

         (c) Judgment upon any award of the arbitrator shall be binding and
shall be entered in a court of competent jurisdiction. The award of the
arbitrator may grant any relief which might be granted by a court of general
jurisdiction, including, without limitation, by reason of enumeration, award of
damages and/or injunctive relief, and may, in the discretion of the

                                       16
<PAGE>   17

arbitrator, assess, in addition, the costs of the arbitration, including the
reasonable fees of the arbitrators and reasonable attorney's fees, against
either or both parties, in such proportions as the arbitrator shall determine.
In the event that the arbitrator makes no such award as to the costs of
arbitration, the parties shall equally pay the costs of arbitration.

         (d) NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS AGREEMENT, NOTHING
CONTAINED IN THIS AGREEMENT SHALL BAR EITHER PARTY'S RIGHT AT ANY TIME TO (i)
SEEK IN A COURT OF COMPETENT JURISDICTION AND OBTAIN TEMPORARY OR PERMANENT
INJUNCTIVE OR OTHER EQUITABLE RELIEF (INCLUDING RELIEF AGAINST THREATENED
CONDUCT THAT WILL CAUSE IT LOSS OR DAMAGES) UNDER THE USUAL EQUITY RULES,
INCLUDING THE APPLICABLE RULES FOR OBTAINING RESTRAINING ORDERS AND PRELIMINARY
AND PERMANENT INJUNCTION; OR (ii) ENFORCE IN A COURT OF COMPETENT JURISDICTION A
FINAL JUDGMENT OR ARBITRAL AWARD.

         (e) The venue for any arbitration pursuant hereto shall be Atlanta,
Georgia. The qualified arbitrator may award to the substantially prevailing
party reasonable attorney's and expenses and the costs of the arbitration.

                IX. REPRESENTATIONS AND WARRANTIES OF THE PARTIES

     Each of the parties hereto hereby represents and warrants to the other as
follows:

     9.1 Organization, Power and Qualification. Each party is duly organized,
validly existing and in good standing under the laws of the state in which it is
organized and has full power to own, lease and operate its properties and assets
and to carry on its business as now being conducted, and is duly qualified and
in good standing to do business in each jurisdiction in which the nature of such
party's business or the ownership or leasing of its properties make such
qualification necessary. Each party has full corporate power to enter into this
Agreement and to consummate the transactions contemplated hereby.

     9.2 Authority; Binding Effect. Each party has full power and authority to
enter into this Agreement and to carry out the transactions contemplated hereby.
The directors, shareholders, members or partners and officers of each party have
taken all action required, whether by law, such party's organizational documents
or otherwise, to authorize the execution and delivery of this Agreement and the
performance of transactions contemplated hereby. The execution, delivery, and
performance of this Agreement constitute the valid and binding agreement of each
party enforceable in accordance with its term.

                                       17
<PAGE>   18

                                X. MISCELLANEOUS

     10.1 Assignment. This Agreement may not be assigned by either party without
the express written consent of the other party to this Agreement; provided,
however, (a) SynerPhy may assign this Agreement to another entity which is
controlled by or under the common control of PhyCor without the prior written
consent of Group so long as such assignment is in connection with a corporate
restructuring and such entity shall assume all of SynerPhy's obligations
hereunder and shall continue to provide services to Group in accordance with the
terms of this Agreement, and (b) Group may assign this Agreement to another
entity so long as such other entity is a newly formed entity formed by the
physicians of Group to provide medical services, no less than seventy-five
percent (75%) of the members of Group are shareholders, partners or members of
such new entity, and Group ceases to operate in connection therewith.

     10.2 Whole Agreement; Modification. This Agreement constitutes the entire
agreement between the parties and it expressly terminates and supersedes the
Service Agreement. There are no agreements or understandings, written or oral,
between the parties regarding this Agreement and the Exhibits, other than as set
forth herein. This Agreement shall not be modified or amended except by a
written document executed by both parties to this Agreement, and such written
modification(s) shall be attached hereto.

     10.3 Notices. All notices required or permitted by this Agreement shall be
in writing and shall be addressed as follows:

     To Group:             Harbin Clinic, L.L.C.
                           1825 Martha Berry Boulevard
                           Rome, GA  30165-1698
                           Attention:  President

     To SynerPhy:          SynerPhy of Rome, Inc.
                           30 Burton Hills Blvd., Suite 400
                           Nashville, TN  37215
                           Attention:  General Counsel

or to such other address as either party shall notify the other.

     10.4 Binding on Successors. This Agreement shall be binding upon the
parties hereto, and their successors, assigns, heirs and beneficiaries.

     10.5 Wavier of Provisions. Any waiver of any terms and conditions hereof
must be in writing, and signed by the parties hereto. The waiver of any of the
terms and conditions of this Agreement shall not be construed as a waiver of any
other terms and conditions hereof.

                                       18
<PAGE>   19

     10.6 Governing Law. The validity, interpretation and performance of this
Agreement shall be governed by and construed in accordance with the laws of the
State of Georgia. The parties acknowledge that SynerPhy is not authorized or
qualified to engage in any activity that may be construed or deemed to
constitute the practice of medicine. To the extent any act or service required
of SynerPhy in this Agreement should be construed or deemed, by any governmental
authority, agency or court to constitute the practice of medicine, the
performance of said act or service by SynerPhy shall be deemed waived and
forever unenforceable and the provisions of Section 10.11 shall be applicable.

     10.7 Severability. The provisions of this Agreement shall be deemed
severable and if any portion shall be held invalid, illegal or unenforceable for
any reason, the remainder of this Agreement shall be effective and binding upon
the parties.

     10.8 Additional Documents. Each of the parties hereto agrees to execute any
document or documents that may be requested from time to time by the other party
to implement or complete such party's obligations pursuant to this Agreement.

     10.9 Attorney's Fees. If legal action is commenced by either party to
enforce to defend its rights under this Agreement, the prevailing party in such
action shall be entitled to recover its costs and reasonable attorneys' fees in
addition to any other relief granted.

     10.10 Time is of the Essence. Time is hereby expressly declared to be of
the essence in this Agreement.

     10.11 Contract Modifications for Prospective Legal Events. In the event any
state or federal laws or regulations, now existing or enacted or promulgated
after the effective date of this Agreement, are interpreted by judicial
decision, a regulatory agency or legal counsel in such a manner as to indicate
that the structure of this Agreement may be in violation of such laws or
regulations, SynerPhy and Group shall amend this Agreement as necessary. To the
maximum extent possible, any such amendment shall preserve the underlying
economic and financial arrangements between SynerPhy and Group.

     10.12 Remedies Cumulative. No remedy set forth in this Agreement or
otherwise conferred upon or reserved to any party shall be considered exclusive
of any other remedy available to any party, but the same shall be distinct,
separate and cumulative and may be exercised from to time as often as occasion
may arise or as may be deemed expedient.

     10.13 Language Construction. The language in all parts of this Agreement
shall be construed, in all cases, according to its fair meaning, and not for or
against either party hereto. The parties acknowledge that each party and its
counsel have reviewed and revised this Agreement and that the normal rule of
construction to the effect that any ambiguities are to be resolved against the
drafting party shall not be employed in the interpretation of this Agreement.

     10.14 No Obligation to Third Parties. None of the obligations and duties of
SynerPhy or Group under this Agreement shall in any way or in any manner be
deemed to create any obligation of SynerPhy or Group to any person or entity not
a party to this Agreement or to create any rights on behalf of any such person
or entity.

                                       19
<PAGE>   20

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the date first written above.

                                    GROUP:

                                    HARBIN CLINIC, L.L.C.

                                    By: /s/
                                        -------------------------------------
                                    Its:_____________________________________

                                    SYNERPHY:

                                    SYNERPHY OF ROME, INC.

                                    By: /s/
                                        ------------------------------------
                                    Its: Vice President

                                       20<PAGE>   1
                                                                   EXHIBIT 10.10

                         EXECUTIVE EMPLOYMENT AGREEMENT

     THIS EXECUTIVE EMPLOYMENT AGREEMENT (the "Agreement") is made effective as
of the 23rd day of March, 1998 ("Effective Date"), by and between PowerCerv
Technologies Corporation, a Florida corporation located at 400 North Ashley
Drive, Suite 2700, Tampa, Florida 33602 (the "Company") and John Montague, an
individual currently residing at 114 8th Street, Huntington Beach, CA 92648 (the
"Executive").

                             BACKGROUND INFORMATION

     A. WHEREAS, the Company is engaged in designing, developing, promoting,
licensing and supporting client/server application products and development
tools, and providing related technical consulting and education services; and

     B. WHEREAS, the Company desires to employ Executive as its Senior Vice
President, Marketing, and Executive desires to be employed by the Company in
this capacity and devote his full time and efforts to the business and affairs
of the Company as described herein, all pursuant to the terms and subject to the
conditions set forth in this Agreement.

                             STATEMENT OF AGREEMENT

     NOW, THEREFORE, in consideration of the foregoing and of the respective
covenants and agreements set forth herein, the receipt and sufficiency of which
are hereby acknowledged, the parties agree as follows:

     1. SENIOR VICE PRESIDENT, MARKETING. The Company hereby agrees to hire
Executive to serve in the capacity of Senior Vice President, Marketing of the
Company in accordance with the provisions of this Agreement. The Executive will
be responsible for managing all marketing activities of the Company, and as
otherwise set forth herein. The Executive will report to Michael Simmons, the
President and Chief Operating Officer of the Company ("President/COO"). The
Executive hereby accepts such employment upon the terms and conditions
hereinafter set forth.

     2. TERM. Unless earlier terminated as provided herein, the term of this
Agreement shall commence on the effective date as set forth above and terminate
on December 31, 2000. The Executive agrees that his actual first day of
employment with the Company, on a full-time basis in Tampa, Florida, shall be on
or before May 18, 1998. Notwithstanding the foregoing, if this Agreement is not
terminated as provided herein on or before the expiration of its initial term,
this Agreement will be automatically renewed for successive one (1) year terms
unless, at least sixty (60) days prior to the expiration of the initial term or
any subsequent one-year renewal term, either party has given written notice to
the other of its intention not to renew this Agreement beyond the end of such
term.

     3. DUTIES.

     (a)  The Executive shall perform all functions and duties consistent with
          his position as described above in Section 1 on behalf of the Company,
          its parent corporation and its affiliates in a faithful, efficient,
          trustworthy and professional manner, as reasonably required by the
          President/COO or as otherwise requested by the Chief Executive Officer
          or Board of Directors of PowerCerv Corporation ("Board of Directors").
          The Executive agrees to comply with all policies and regulations of
          the Company and the terms and conditions of this Agreement, to devote
          his best efforts to the interests of the Company, and

                                       1
<PAGE>   2

          will not, without the prior written consent of the President/COO,
          engage in any other job or activity detrimental to the Company's
          interests or in contravention to the terms and conditions of this
          Agreement. The Executive shall be principally based at the Company's
          corporate offices in Tampa, Florida and shall travel as required in
          connection with the performance of his duties hereunder. During the
          term of this Agreement (following his actual first day of employment),
          the Executive shall devote substantially all of his working time and
          efforts to the business and affairs of the Company. The Executive
          shall, upon request of the Company, perform services for any parent,
          subsidiary or affiliate of the Company without compensation except as
          provided herein.

     (b)  In addition, the Executive represents that he has not brought to the
          Company, and will not bring or use in the performance of his duties at
          the Company, any property, trade secrets or confidential information
          (whether or not in writing) of a former employer or third party
          without that employer's or third party's written consent. The
          Executive hereby certifies that he is not a party to any other
          agreement (or subject to any fiduciary obligation) which will
          interfere with the Executive's full compliance with this Agreement.
          The Executive has not entered into any agreement or understanding
          either written or oral in conflict with the provisions of this
          Agreement. The Executive acknowledges and agrees that the Company is
          hiring him based upon its understanding that the Executive will be
          fully capable, without restriction, of performing under this Agreement
          in his capacity as Senior Vice President, Marketing for the Company,
          and that the Company is relying upon the representations set forth
          herein in connection with its providing this Agreement to the
          Executive.

     4. COMPENSATION. As his entire compensation for all services rendered to
the Company during the term of this Agreement, the Executive shall receive the
compensation provided for in this Section, subject to withholding and other
applicable employment taxes:

     (a)  Base Salary. Effective upon the Executive's actual first day of
          employment with the Company, the Company will pay the Executive an
          annual base salary (the "Base Salary") of $150,000. The Base Salary
          will be paid on or about the 15th and 30th of each working month at a
          rate of $12,500 per month all pursuant to the provisions of this
          Agreement. The Base Salary shall be subject to review on an annual
          basis by the Compensation Committee of the Board of Directors, as
          recommended by the President/COO. The Compensation Committee shall not
          have the authority to reduce the Base Salary from the level set forth
          in this Agreement.

     (b)  Target Annual Bonus. The Executive will be eligible to potentially
          earn an annual bonus of $150,000 (the "Target Annual Bonus") per the
          provisions of this Section 4(b) for each of the Company's three (3)
          fiscal years during the term of this Agreement. The Executive's Target
          Annual Bonus will be pro-rated during the Company's 1998 fiscal year
          based upon the percentage of the Company's 1998 fiscal year which the
          Executive actually worked for the Company. For each fiscal thereafter
          during the term of this Agreement, no such pro-rating of Executive's
          Target Annual Bonus will occur. The Target Annual Bonus will be paid
          in one lump sum for each of such fiscal years, subject to the Company
          and/or Executive, as applicable, achieving certain criteria as
          hereinafter set forth. References below to target revenues and target
          operating income relate to Company's "Management Plan Projections"
          approved by the Board of Directors no less frequently than annually in
          advance of the period or which the targets are being determined.
          Actual revenues and actual operating income shall be computed on a
          basis consistent with a method by which target revenues and target
          operating income for the related year were computed. Eligibility for
          payments of this component of the Target

                                        2
<PAGE>   3

          Annual Bonus to Executive shall be for each of the Company's fiscal
          years during the term of the Agreement beginning with the fiscal year
          commencing January 1, 1998 and shall be computed as follows:

               (i)  $52,500 will be earned upon Company achieving target
                    revenues for each fiscal year;

               (ii) $52,500 will be earned upon Company achieving target
                    operating income for each fiscal year; and

              (iii) $45,000 will be earned upon approval of the Board of
                    Directors after its review of the Executive Management
                    and/or Executive's presentation of strategic business
                    accomplishments of the Company for each fiscal year.

          If a target referenced in subclause (i) or (ii) above is not met in a
          particular fiscal year, Executive shall not receive for such fiscal
          year the part of the Target Annual Bonus tied to such target. With
          respect to subclause (iii) above, the presentation by the Executive
          Management and/or Executive of Company's strategic business
          accomplishments for a fiscal year shall be promptly evaluated by the
          Board of Directors and the potential related bonus shall be determined
          by the Board of Directors in its reasonable discretion. The Executive
          shall be eligible to earn all or a portion of such potential bonus as
          so determined by the Board of Directors. All amounts payable pursuant
          to this Section 4(b) shall be paid to the Executive promptly after the
          amount is determined. Additionally, the Executive acknowledges and
          agrees that no advances or draws will be paid under this Agreement.
          The Executive's Target Annual Bonus shall be subject to review on an
          annual basis by the Compensation Committee of the Board of Directors,
          as recommended by the President/COO.

     (c)  Stock Options. As of the Effective Date of this Agreement, the Company
          agrees to grant the Executive those stock options set forth below in
          subsections 4(c)(i) and 4(c)(ii). The Executive acknowledges and
          agrees that during the initial term of this Agreement (through
          December 31, 2000), the Executive will not receive nor be entitled to
          receive any additional stock options from the Company other than as
          set forth in this Agreement. In addition, the Executive acknowledges
          that all stock options being granted to him below are not part of or
          granted pursuant to the Company's 1995 Stock Option Plan, as amended,
          and accordingly constitute "non-qualified stock options" for purposes
          of the Internal Revenue Code of 1986, as amended (the "Code"). If the
          Company and the Executive determine that no exemption from the
          registration requirements from the Securities Act of 1933 is available
          with respect to the shares to be issued upon exercise of the options,
          the Company will file a registration statement with respect to such
          shares. The stock options to be granted to the Executive on the
          Effective Date are as follows:

          i)   A non-transferable option to purchase 225,000 shares of the
               Company's common stock pursuant to a "PowerCerv Corporation Stock
               Option Agreement". The exercise price for this option will be the
               "fair market value" on the date of grant, which shall be the
               average of the high and low sales prices of the Company's common
               stock as reported by the NASDAQ on the Effective Date of this
               Agreement. If trading in the stock or a price quotation does not
               occur on the date as of which fair market value is being
               determined, the last date on which the stock was traded or a
               price was quoted shall determine the fair market value.

                                        3
<PAGE>   4

               This option will vest according to the schedule set forth on
               Exhibit A attached hereto and incorporated herein by this
               reference.

               The stock option described in subsection 4(c)(i) will expire on
               the earlier of (x) ten (10) years from the date of grant, or (y)
               the first anniversary of the date of the Recipient's death or
               disability, or (z) one hundred and fifty (150) days following the
               Executive's separation of employment from the Company.

          ii)  A second non-transferable option to purchase 75,000 shares of the
               Company's common stock pursuant to a "PowerCerv Corporation Stock
               Option Agreement". The exercise price for this option will be the
               "fair market value" on the date of grant, which shall be the
               average of the high and low sales prices of the Company's common
               stock as reported by the NASDAQ on the Effective Date of this
               Agreement. If trading in the stock or a price quotation does not
               occur on the date as of which fair market value is being
               determined, the last date on which the stock was traded or a
               price was quoted shall determine the fair market value. This
               option will vest according to the schedule set forth on Exhibit B
               attached hereto and incorporated herein by this reference.

               The stock option described in subsection 4(c)(ii) will expire on
               the earlier of (x) ten (10) years from the date of grant, or (y)
               the first anniversary of the date of the Recipient's death or
               disability, or (z) one hundred and fifty (150) days following the
               Executive's separation of employment from the Company. The
               Compensation Committee of the Board of Directors may, at its sole
               discretion, review the Executive's performance in light of the
               Company's operating plan to determine whether or not to
               accelerate the vesting of any portion of the stock price-based
               stock options.

     (d)  Relocation. In addition to the compensation described above, the
          Company will pay the Executive a one-time "Relocation Allowance" of
          $30,000, on a pre-tax basis. The Executive agrees to use the
          Relocation Allowance exclusively for his relocation expenses, and will
          request such payment in writing from the President/COO. If the
          Executive separates his employment with the Company without Cause (as
          "Cause" is defined in Section 9(a) of the Agreement) on or before May
          18, 1999, the Executive agrees to promptly return the entire amount of
          the Relocation Allowance to the Company. In addition to the Relocation
          Allowance described above, the Company agrees to reimburse the
          Executive up to $1,500 per month for no more than six (6) months from
          the Effective Date for his and his family's temporary travel and
          living expenses in Tampa. In connection with obtaining such
          reimbursement, the Executive agrees to submit expense receipts for
          these travel/living costs.

     (e)  Additional Stock Option. In addition to the stock options set forth in
          Section 4(c) above, the Company agrees to grant to the Executive an
          option to purchase 22,736 shares of the Company's common stock
          according to the terms and conditions of the Company's 1995 Stock
          Option Plan, as amended. The exercise price for the option will be the
          fair market value on the Effective Date of this Agreement. This option
          will be treated as a "non-qualified stock option" for purposes of the
          Code, and will vest 33% at December 31, 1998, an additional 33% at
          December 31, 1999, and an additional 34% at December 31, 2000, so that
          on December 31, 2000, this stock option will be 100% fully-vested.

                                       4
<PAGE>   5

     5. WORKING FACILITIES. The Company shall provide the Executive with office
space, equipment, facilities, staffing and services which are suitable to the
position of Senior Vice President, Marketing and adequate for the performance of
the Executive's duties hereunder.

     6. EXPENSES. The Company shall reimburse the Executive for all reasonable
travel and other business expenses incurred by him in furtherance of the
Company's business in accordance with the Company's written policies and
procedures.

     7. VACATION AND HOLIDAYS. The Executive shall be entitled to such vacation
with pay and holidays with pay during each fiscal year of the Company as shall
be approved by the Company. The amount of vacation and holidays provided to the
Executive shall be consistent with the amount given other comparable executive
employees of the Company.

     8. HEALTH, WELFARE AND INSURANCE PLANS. Subject to eligibility
requirements, the Executive will be entitled to participate in any plans,
insurance policies or contracts maintained by the Company relating to
retirement, health, disability and other related benefits. The Executive's
rights with respect to any such benefits shall be subject to the provisions of
the relevant plans, policies or contracts providing such benefits. Nothing
contained herein shall be deemed to impose any obligation on the Company to
adopt or maintain any such plan, policy or contract. As of the date of this
Agreement, the Company does not provide different types or levels of health,
welfare and insurance plan or benefit coverage to its executive employees, and
further, there is no present intention by the Company to change this benefit
policy. However, if the Company were to change its policy relative to executive
benefits, those health, welfare and insurance plan and benefit coverage made
available to the Executive will be consistent with the amount given other
comparable executive employees of the Company.

     9. TERMINATION. This Agreement, and the Executive's employment hereunder,
shall terminate in accordance with the provisions of this Section of the
Agreement.

     (a)  By Company. The Company may terminate this Agreement (i) with Cause at
          any time upon thirty (30) days prior written notice to the Executive,
          (ii) upon the Company's merger, consolidation, acquisition,
          liquidation, sale or other disposition of all or substantially all of
          its business and/or assets to a third party; or (iii) without Cause
          upon ninety (90) days prior written notice to the Executive, and the
          Executive shall work for the Company during such notice period unless
          otherwise directed by the Company.

          As used in this Agreement, the term "Cause" shall mean (A) willful and
          repeated failure to comply with the lawful directions of the
          President/COO, Chief Executive Officer or Board of Directors or
          repeated failure to perform the duties as Senior Vice President,
          Marketing of the Company; (B) gross negligence or willful misconduct
          in the performance of duties to the Company and/or its subsidiaries;
          (C) commission of any act of fraud with respect to the Company and/or
          its subsidiaries; or (D) conviction of a felony or a crime involving
          moral turpitude causing material harm to the standing and reputation
          of the Company and/or its subsidiaries, in each case as determined in
          good faith by the Board of Directors.

     (b)  Death. This Agreement shall terminate immediately upon the Executive's
          death.

     (c)  Disability. If the Executive incurs a Disability (as defined below)
          which continues for a period of at least ninety (90) consecutive days,
          this Agreement shall terminate on the last day of such period. Unless
          the Executive shall perform his duties hereunder for a

                                       5
<PAGE>   6

          continuous period of at least thirty (30) consecutive days following a
          period of Disability before the Executive again incurs a Disability,
          he shall not be entitled to start a new ninety (90) consecutive day
          period under the provisions of this subsection, but instead may only
          continue under the remaining portion of the original ninety (90)
          consecutive day period.

          As used in this Agreement, the term "Disability" shall mean the
          Executive's physical or mental inability, by reason of illness or
          accident, to perform the normal duties of his employment by the
          Company, subject to any obligation the Company may have under
          applicable law to provide reasonable accommodation. If there is any
          disagreement between the Company and the Executive as to the
          Executive's Disability or as to the date any such Disability began or
          ended, the same shall be determined by a physician mutually acceptable
          to the Company and the Executive. The determination of such physician
          shall be conclusive evidence of any such Disability and of the date
          any such Disability began or ended. The Executive shall be available
          for such an examination at any reasonable time upon prior reasonable
          notice thereof from the Company. If the Executive fails or refuses to
          cooperate in such examination, the determination of the Executive's
          Disability and the date any such Disability began or ended shall be
          made by the Company in its sole discretion.

     (d)  Termination by Executive. The Executive may terminate this Agreement
          (i) for Good Reason at any time upon thirty (30) days prior written
          notice to the Company, or (ii) at any time upon ninety (90) days prior
          written notice to the Company; provided, however, the Executive shall
          continue to work for the Company during such notice period unless
          otherwise directed by the Company.

          As used in this Agreement, "Good Reason" shall mean (A) any material
          breach of this Agreement by the Company which has not been cured
          within thirty (30) days of the Company's receipt of written notice of
          such breach from the Executive, or as soon thereafter as practicable
          so long as the Company is diligently seeking to cure such failure or
          breach; or (B) a material reduction in the Executive's title(s) or
          responsibilities unless replaced with a new title or new
          responsibilities of comparable stature or value to the Company within
          thirty (30) days.

     10. PAYMENTS BY COMPANY UPON TERMINATION.

     (a)  Within ten (10) business days following the effective date of the
          termination of the Executive's employment (the "Termination Date") if
          based upon the Company's termination of the Executive with Cause as
          described under Section 9(a)(i); or the Executive's death as described
          under Section 9(b); or the Executive's Disability as described under
          Section 9(c); or the Executive's notice of termination to the Company
          without Good Reason as described under Section 9(d)(ii), then the
          Company shall pay the Executive (or his estate in the case of death
          per Section 9(b)) his Base Salary prorated through the Termination
          Date plus any life insurance, disability or other benefits to which
          the Executive is entitled in accordance with the terms and conditions
          of the Company's health, welfare and insurance plans.

     (b)  If the Company is merged, consolidated, acquired, sold, liquidated, or
          any other disposition of all or substantially all of its business
          and/or assets to a third party as described under Section 9(a)(ii)
          above and in which the Executive is not then offered an equal or
          better position, salary and compensation package (as adjusted to
          reflect cost of

                                       6
<PAGE>   7

          living increases), relocation package and other benefits with said
          third party; or if the Company has given notice of termination to the
          Executive as described under Section 9(a)(iii); or if the Executive
          has given notice of termination to the Company under Section 9(d)(i),
          then in any one of these circumstances, and further provided that the
          Executive is not in breach of Sections 11, 12 and 13 of this Agreement
          or does not subsequently breach any of said sections, then Company
          shall: (i) pay the Executive an amount equal to twelve (12) months of
          the Executive's then current year Base Salary, payable in twelve (12)
          equal monthly installments from his Termination Date; (ii) provide
          health, life and such other insurance benefits to the Executive and
          dependents that he would have received during said twelve (12) month
          period following the Termination Date had such termination not
          occurred (or if such insurance plans are no longer available [in the
          case of the Company's acquisition], reimbursement by the Company to
          the Executive of his reasonable costs for the same or similar
          insurance); and (iii) vest the Executive's stock options in accordance
          with Section 10(c) below. The obligation of the Company to pay such
          severance and vest stock options is contingent upon the Executive's
          compliance with Sections 11, 12 and 13 of this Agreement (as indicated
          above) and the Executive's execution of a severance and general
          release agreement reasonably satisfactory in form and substance to the
          Company.

     (c)  For purposes of vesting the unvested portions of the Executive's
          outstanding stock options, if the Company is merged, consolidated,
          acquired, sold, liquidated or any other disposition of all or
          substantially all of its business and/or assets to a third party as
          described under Section 9(a)(ii), and provided there is no "pooling"
          concern, then one hundred percent (100%) of all outstanding stock
          options then held by the Executive shall vest upon the effective date
          of such event. If either (i) the Company has given notice of
          termination to the Executive as described under Section 9(a)(iii) of
          the Agreement, or (ii) the Executive has given notice of termination
          to the Company under Section 9(d)(i) of the Agreement, and provided
          there is no "pooling" concern, then those stock options which would
          have vested over the next twelve (12) month period immediately
          following the Termination Date shall vest upon the Termination Date,
          and no further vesting of any nature shall occur with respect to any
          other stock options then held by the Executive. To the extent there
          would be a "pooling" concern, the Company and the Executive agree to
          work together in good faith to carry out the intent of this provision
          and preserve the Company's ability to do a "pooling" transaction. If
          the accelerated vesting of the options hereunder would (x) subject the
          Executive to a tax pursuant to Section 4999 of the Code (or any
          successor provision that may be in effect), or (y) result in a
          disallowance of a deduction to the Company for all or any part of the
          compensation attributable to the option by reason of Section 280G of
          the Code (or any successor provision that may be in effect), the
          Company shall reduce, eliminate or postpone the acceleration of the
          vesting of the option to the extent necessary to reduce the "present
          value" (as this term is defined in Section 280G(d)(4) of the Code, or
          any successor provision that may be in effect) of the compensation
          attributable to the accelerated vesting to one dollar less than an
          amount equal to three times the Executive's "base amount" (as this
          term is defined in Sections 280G(b)(3) and 280G(d) of the Code, or any
          successor provisions that may be in effect).

     (d)  Except as provided in subsection (a), (b) and (c) above, the Executive
          (or his estate, if applicable) shall not be entitled to receive
          severance pay or any other compensation upon any termination of his
          employment.

     11. EMPLOYMENT POLICIES. The Executive shall abide by all policies and
procedures of the Company in effect from time to time.

                                       7
<PAGE>   8

     12. CONFIDENTIALITY AND INVENTIONS CLAUSES.

     (a)  The Executive agrees not to disclose the terms and conditions of this
          Agreement to any other employee of the Company or any other party
          except the Executive may disclose such information to his immediate
          family, financial advisors or attorneys.

     (b)  The Executive agrees to hold in confidence and not use or disclose
          without the Company's prior written consent (i) any information
          (technical or otherwise) that he obtains or creates during the term of
          this Agreement which pertains to any aspect of the Company's business
          or (ii) any information received in confidence by the Company from a
          third party, until such information becomes generally known by the
          public. The Executive shall not make any unauthorized copies of such
          information and will return to the Company, upon termination of his
          employment or upon the Company's request, all tangible forms of such
          information, including, without limitation, sales plans, marketing
          plans, compensation plans, business strategies, product strategies,
          internet or intranet strategies, business or product development
          strategies, financial information, partner and customer relationships,
          and other information about former, current, or prospective
          partners/customers, employee lists and other information about former,
          current, or prospective employees, software programs (source or object
          codes), know-how, new product offerings, plans, projections,
          confidential business information, copyrights, trade secrets, and any
          other proprietary material.

     (c)  The Executive hereby assigns to the Company all of his rights in all
          intellectual property (including, but not limited to, trade secrets,
          know-how, inventions, copyrights, designs, computer programs and
          software techniques) that the Executive conceives or develops, in
          whole or in part, during his employment with the Company. This
          assignment does not cover any intellectual property which: (i) is
          conceived and developed entirely on the Executive's own time; (ii) is
          conceived and developed without any Company equipment, supplies,
          facilities, or trade secrets; and (iii) does not relate to Company's
          current or future business or to the Company's actual or demonstrably
          anticipated research or development efforts. The Executive understand
          that this assignment does not cover any inventions completed prior to
          his employment with the Company, which inventions are specifically
          identified on a schedule which the Executive has presented to the
          Company and has been attached to this Agreement on or before the
          Effective Date hereof (which contains no confidential information).
          During and after the Executive's employment with the Company, the
          Executive agrees to do whatever is requested by the Company, at the
          Company's expense, to sign documents or otherwise assist in obtaining,
          confirming, and enforcing the Company's rights in the assigned
          property throughout the world.

     13. NON-COMPETE.

     (a)  During the term of this Agreement, as extended, the Executive may
          learn of confidential matters essential to the business and
          competitive position of the Company, including, without limitation,
          its sales and marketing plans and strategies, business or product
          development strategies, financial information, partner and customer
          relationships, and other information about former, current, or
          prospective partners/customers, employee lists and other information
          about former, current, or prospective employees, software programs
          (source or object codes), research and development plans, know-how,
          projections, copyrights, trade secrets, or any other proprietary
          material and confidential business information that would unfairly
          disadvantage the Company were the Executive to use or disclose such
          information in business activities competitive with the Company. The

                                       8
<PAGE>   9

          Executive also may develop contacts and relationships with (i) former,
          current, or prospective customers of the Company or (ii) former,
          current, or prospective business partners, or licensors of the Company
          which, if those contacts or relationships were used by the Executive
          in competition with the Company, would unfairly disadvantage the
          Company. To protect the Company's trade secrets, confidential business
          information, and current and prospective business relationships, the
          Executive shall not, during the term of this Agreement and for a
          period of twelve (12) months immediately following the Termination
          Date for whatever reason, whether voluntary or involuntary (with or
          without cause), directly or indirectly, either as an individual on the
          Executive's own account or as a partner, employee, agent, contractor,
          officer, director, stockholder, or otherwise:

          (I)  Hire, solicit for hire, refer, or retain the services of any
               employee of the Company or its subsidiary for any matter
               whatsoever during the period of time which said employee is
               employed by the Company or its parent, subsidiaries or affiliates
               and for six (6) months thereafter; or

          (II) Engage in, consult with, or accept employment from any business
               in current or prospective competition with the Company
               (excluding, however, those companies with whom the Executive
               actually had a direct relationship with prior to his becoming an
               employee of the Company or as otherwise proven by the Executive)
               where such engagement, consultation, or employment is likely to
               require the Executive to use or disclose trade secrets or
               confidential business information of the Company. For purposes of
               the "pre-existing relationship" exclusion described in
               subsections (a) and (c) of this Section 13(a), the parties agree
               that the burden of proof to establish the existence of this
               relationship will be on the Executive. In addition to and for
               purposes of this subclause (II), the Company and the Executive
               agree that the marketing and sales information, methods and
               techniques created and/or used by the Executive prior to May 18,
               1998 will not be considered trade secrets or confidential
               business information of the Company.

     (b)  The Executive acknowledges that, in the course of his employment with
          the Company, the Executive may (i) obtain information and knowledge of
          confidential matters essential to the business and competitive
          position of the Company and (ii) have contacts with customers,
          partners or vendors of the Company, which information and knowledge
          and contacts are being so provided to the Executive in reliance upon
          his execution of this Agreement. The Executive hereby acknowledges the
          sufficiency of consideration for this Agreement, and the Executive
          further acknowledges that the confidentiality and customer/vendor
          protection covenants in this Agreement are reasonable and necessary to
          protect the valid business interests of the Company, including the
          Company's valuable trade secrets, other confidential business
          information, and relationships with its former, current, and
          prospective customers, business partners, licensors, and vendors.

     (c)  If any of the provisions of Sections 11, 12 or 13 are found to be
          unreasonable in duration, geographical scope, or line of business, the
          provision shall not be rendered unenforceable by this finding, but
          rather the duration, geographical scope, or line of business of such
          provision shall be deemed automatically reduced or modified with
          retroactive effect to the extent necessary to render the provision
          enforceable, and such provision shall be enforced as modified.

                                       9
<PAGE>   10

     (d)  The parties to this Agreement acknowledge and agree that damages in
          the event of a breach of any of the provisions of Sections 11, 12 or
          13 by the Executive would be difficult to ascertain, and therefore the
          Company, in addition to and not in limitation of any other rights,
          remedies or damages available to it in law or in equity, shall have
          the right to injunctive or other equitable relief in any court of
          competent jurisdiction, enjoining such breach.

     14. INDEMNIFICATION. The Executive shall be, and hereby is, indemnified by
the Company, to the fullest extent permitted by applicable law, for all costs,
claims, expenses (including reasonable attorney's fees and other litigation
costs), damages and losses incurred by Executive by reason of being employed, or
serving in any capacity, as an employee or officer of the Company or any
affiliate thereof.

     15. SUCCESSORS; BINDING AGREEMENT.

     (a)  The Company will require any successor (whether by merger,
          consolidation, purchase, acquisition or otherwise) to all or
          substantially all of the business and/or assets of the Company, to
          expressly assume and agree to perform this Agreement in the same
          manner and to the same extent that the Company would be required to
          perform it if no such succession had taken place. As used in this
          Section 15(a), "Company" shall mean the Company as hereinbefore
          defined and any successor to its business and/or assets as aforesaid
          which executes and delivers the agreement provided for in this Section
          or which otherwise becomes bound by all the terms and provisions of
          this Agreement by operation of law.

     (b)  This Agreement and all rights of the Executive hereunder shall inure
          to the benefit of and be enforceable by the Executive's personal or
          legal representatives, executors, administrators, successors, heirs,
          distributees, devisees and legatees.

     16. MISCELLANEOUS.

     (a)  Notice. Any notice required or permitted to be given hereunder shall
          be in writing and shall be deemed to have been given three (3)
          calendar days following the day in which it is personally delivered or
          deposited in the United States certified mail, return receipt
          requested and postage prepaid. Any such notice so mailed to the
          Executive shall be addressed to the Executive's last known residence
          address. Any such notice so mailed to the Company shall be addressed
          to its principal office in Tampa, Florida.

     (b)  Modification. No provisions of this Agreement may be modified, waived
          or discharged unless such waiver, modification or discharge is agreed
          to in writing signed by the Founders or their designee and the
          Executive.

     (c)  Waiver of Breach or Violation Not Deemed Continuing. The waiver by
          either party of a breach or violation of any provision of this
          Agreement shall not operate as, or be construed to be, a waiver of any
          subsequent breach hereof.

     (d)  Assignment. The Executive shall not assign all or any portion of his
          rights, obligations, or duties under this Agreement to any third party
          without the prior written approval of the Company. Any assignment in
          violation of this provision shall be void and of no force or effect.

                                       10
<PAGE>   11

     (e)  Necessary Action. Each party shall perform any further acts and
          execute and deliver any documents which may be reasonably necessary to
          carry out the provisions of this Agreement.

     (f)  Attorneys Fees. In the event of a dispute arising under or in
          connection with this Agreement, the prevailing party shall be entitled
          to collect from the other party all reasonable legal fees and
          expenses.

     (g)  Venue. The Executive hereby consents to personal jurisdiction and
          venue, for any action brought by the Company arising out of a breach
          or threatened breach of this Agreement, exclusively in the United
          States District Court for the Middle District of Florida, Tampa
          Division, or in the Circuit Court in and for Hillsborough County,
          Florida. The Executive hereby agrees that any action brought by him,
          alone or in combination with others, against the Company, whether
          arising out of the Agreement or otherwise, shall be brought
          exclusively in the United States District Court for the Middle
          District of Florida, Tampa, Division, or in the Circuit Court in and
          for Hillsborough County, Florida. The Executive hereby agrees that any
          controversy which may arise under this Agreement would involve
          complicated and difficult factual and legal issues. Therefore, if a
          court of law determines for any reason that the arbitration clause of
          Section 16(h) of this Agreement is unenforceable, then any action
          brought by the Company against the Executive or brought by Executive,
          alone or in combination with others, against the Company, whether
          arising out of this Agreement or otherwise, shall be determined by a
          judge sitting without a jury.

     (h)  Arbitration. All controversies, claims, disputes, and matters in
          question arising out of, or related to, this Agreement or the breach
          of this Agreement, or the relations between the signatories to this
          Agreement, shall be decided by arbitration in accordance with the
          Commercial Arbitration Rules of the American Arbitration Association.
          The parties agree that the arbitration shall take place exclusively in
          Tampa, Florida, and shall be governed by the substantive law of the
          state of Florida. Any award rendered by the arbitrator shall be final,
          and final judgment may be entered upon the parties in accordance with
          applicable law in any court having jurisdiction thereof, including a
          federal district court, pursuant to the Federal Arbitration Act. The
          arbitrator may grant the Company injunctive relief, including
          mandatory injunctive relief, to protect the rights of the Company, but
          the arbitrator shall not be limited to such relief. This arbitration
          provision shall not preclude the Company from seeking temporary or
          preliminary injunctive relief in a court of law to protect its rights,
          nor shall the filing of such an action constitute any waiver by the
          Company of its right to arbitrate. In connection with the arbitration
          of any dispute between the signatories to this Agreement, each
          signatory may utilize all methods of discovery authorized by the
          Federal and Florida Rules of Civil Procedure.

                  [remainder of page intentionally left blank]

                                       11
<PAGE>   12

     (i)  Entire Agreement. This Agreement, including any attached schedules,
          contains the entire agreement of the parties relating to the subject
          matter hereof and supersedes all prior understandings and agreements
          related to Executive's employment with the Company.

     IN WITNESS WHEREOF, the Company and the Executive have executed this
Agreement as of the date first above written.

WITNESSED BY:                      EXECUTIVE:

/s/ Michael J.                     /s/ John Montague
----------------------------       ---------------------------------------------
                                   John Montague

----------------------------

                                   POWERCERV TECHNOLOGIES CORPORATION

                                   By: /s/ Marc J. Fratello
                                       -----------------------------------------
                                       Marc J. Fratello, Chief Executive Officer

                                       12
<PAGE>   13

                                    EXHIBIT A

<TABLE>
<CAPTION>
                                                        SHARES WITH RESPECT TO WHICH
                  DATE                                THE STOCK OPTION IS EXERCISABLE
                  ----                                -------------------------------
<S>                                                   <C>
Executive's employment commencement date                            50,000
May 31, 1998                                                        53,977
June 30, 1998                                                       57,954
July 31, 1998                                                       61,931
August 31, 1998                                                     65,908
September 30, 1998                                                  69,885
October 31, 1998                                                    73,862
November 30, 1998                                                   77,839
December 31, 1998                                                   81,816
January 31, 1999                                                    85,793
February 28, 1999                                                   89,770
March 31, 1999                                                      93,747
April 30, 1999                                                      97,724
May 31, 1999                                                       101,701
June 30, 1999                                                      105,678
July 31, 1999                                                      109,655
August 31, 1999                                                    113,632
September 30, 1999                                                 117,609
October 31, 1999                                                   121,586
November 30, 1999                                                  125,563
December 31, 1999                                                  129,540
January 31, 2000                                                   133,517
February 29, 2000                                                  137,494
March 31, 2000                                                     141,471
April 30, 2000                                                     145,448
May 31, 2000                                                       149,425
June 30, 2000                                                      153,402
July 31, 2000                                                      157,379
August 31, 2000                                                    161,356
September 30, 2000                                                 165,333
October 31, 2000                                                   169,310
November 30, 2000                                                  173,287
December 31, 2000                                                  177,264
January 31, 2001                                                   181,241
February 28, 2001                                                  185,218
March 31, 2001                                                     189,195
April 30, 2001                                                     193,172
May 31, 2001                                                       197,149
June 30, 2001                                                      201,126
July 31, 2001                                                      205,103
August 31, 2001                                                    209,080
September 30, 2001                                                 213,057
October 31, 2001                                                   217,034
November 30, 2001                                                  221,011
December 31, 2001                                                  225,000
</TABLE>

                                       13
<PAGE>   14

                                    EXHIBIT B

<TABLE>
<CAPTION>
                                                                            SHARES WITH RESPECT TO WHICH
                                   EVENT                                   THE STOCK OPTION IS EXERCISABLE
                                   -----                                   -------------------------------
<S>                                                                        <C>
This option shall become vested on December 31, 2001; provided, however, that
this option may become vested prior to December 31, 2001 based upon the
performance of the Company's common stock as traded on the NASDAQ as follows:
   -    $5.00/share or higher close price
                for 20 consecutive trading days                                       25,000
   -     $9.00/share or higher close price
                for 20 consecutive trading days                                       25,000
   -     $14.00/share or higher close price
                for 20 consecutive trading days                                       25,000
</TABLE>

                                       14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00024-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00024-of-00352.parquet"}]]